perimenopause syndrome
Conditions
Interventions
intervention group:acupuncture with branch-foundation acupoint combination
control group:routine selection of acupoints
Sponsors
Hubei Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
40 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnosis standard for perimenopausal syndrome in Practical Obstetrics and Gynecology released by People's Medical Publishing House, 2013; 2. Aged 40 to 55 years old; 3. the modified Kupperman score>15; 4. willing to participate and signing the inform consent.
Exclusion criteria
Exclusion criteria: 1. prior hysterectomy and/or oophorectomy; 2. with malignant cancer or history of chemotherapy and/or irradiation; 3. unstable thyroid disease; 4. Taking hormone medicines or other drugs associated with the diseases like black cohosh, phytoestrogens, clonidine, veralipride, SSRIs etc during the 12 weeks before the study; 5. With ovarian cysts or uterine fibroids with a diameter greater than 4cm or agnogenic vaginal bleeding; 6. With mandatory indications of hormone therapy, such as menopause after surgery, active osteoporosis, etc; 7. With serious heart, lung, liver, kidney, and nerve, blood system diseases and diabetic neuropathy; 8. Coagulation defeats, or taking anticoagulant drugs, such as warfarin, heparin, etc; 9. Dermal diseases, such as eczema, psoriasis, etc; 10. With smoking or drinking or drug abuse problems; 11. With mental illness and cant take care of themselves; 12. Low compliance; 13. Participate in other clinical trials. Meeting any one of the above 13 will not be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Kupperman score: changes and change rate in modified Kupperman score compared with baseline; | — |
Secondary
| Measure | Time frame |
|---|---|
| An average of 24 hours of hot points: changes in an average of 24 hours of hot points compared with baseline;MENQOL score: changes in MENQOL score compared with baseline;Serum level of sex hormone: changes in FSH, LH, E2 in serum compared with baseline; | — |
Countries
China
Contacts
Public ContactZhou Zhong-yu
Hubei Provincal Hospital of Traditional Chinese Medicine
Outcome results
None listed